-

06:02:33 AM

SNCE Stock News

SNCE - Science 37 Holdings Inc

05/12/22 4:01 PM

Nasdaq : SNCE

clinical trial

Science 37 Introduces Virtual Site Model to Rescue Slow Enrolling Clinical Trials

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today introduced a rapid-deployment

RHEA-AI

neutral

05/10/22 7:55 AM

Nasdaq : SNCE

clinical trial

Science 37® Extends Leadership in Decentralized Clinical Trial Market with NextGen SaaS Release to Fully Orchestrate Decentralized Study Conduct

New release sets the bar as the most comprehensive platform to orchestrate decentralized study conduct—unifying stakeholder journeys, increasing compliance, and generating the highest-quality data for agile trial designs requiring remote and on-premise management RESEARCH TRIANGLE PARK, N.C., May

RHEA-AI

positive

05/09/22 6:00 AM

Nasdaq : SNCE

earnings

Science 37 Reports First Quarter 2022 Financial Results

Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial results for the quarter ended March 31, 2022. "The first quarter of 2022 was marked by continued

RHEA-AI

negative

04/25/22 7:55 AM

Nasdaq : SNCE

conferencesearnings

Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report first quarter 2022 financial results before the market opens on Monday, May 9, 2022. Company management will host a

RHEA-AI

neutral

03/31/22 7:55 AM

Nasdaq : SNCE

Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic Depth

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating

RHEA-AI

neutral

03/22/22 7:00 AM

Nasdaq : SNCE

earnings

Science 37 Reports Fourth Quarter and Full Year 2021 Financial Results

Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial results for the quarter and full year ended December 31, 2021. “Our impressive financial performance

RHEA-AI

neutral

03/08/22 7:55 AM

Nasdaq : SNCE

conferencesearnings

Science 37 to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report fourth quarter and full year 2021 financial results before the market opens on Tuesday, March 22, 2022. Company

RHEA-AI

neutral

03/01/22 7:55 AM

Nasdaq : SNCE

clinical trial

New Science 37® CNS Survey Confirms Growing Trend in Clinical Trials Landscape

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today

RHEA-AI

neutral

02/24/22 7:55 AM

Nasdaq : SNCE

Science 37®’s Operating System Receives ISO Certification for Information Security Management

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today

RHEA-AI

neutral

02/23/22 7:55 AM

Nasdaq : SNCE

conferences

Science 37® to Present at the Cowen 42nd Annual Health Care Conference

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Cowen 42 nd Annual Health Care Conference. Science 37’s management is scheduled

RHEA-AI

neutral